Skip to main content

Home/ MaRS/ Group items tagged clinical trials

Rss Feed Group items tagged

Assunta Krehl

Quest for a wonder drug started with shrew bait - The Globe and Mail - August 8, 2012 - 0 views

  •  
    "Jack Stewart a biotechnology entrepreneur, is about to start a human trial for a drug developed from a compound found in shrew spit that could treat ovarian, breast and prostate cancers without many of the side effects of chemotherapy." Veronika Litinski, a Senior Advisor at MaRS in the Life Science and Health care practice says it is difficult to run trials with a clear robust criteria.
Assunta Krehl

Tiny particles expand frontier of medicine - The Star - February 27, 2010 - 1 views

  •  
    Nanomedicine is a field that is growing and there will be an exponential growth in products. U of T scientists David Jaffray and Christine Allen are amongst those that are going through clinical trials. Allen and Jaffray's invention is being shephered to market by MaRS Innovation.
George Botos

Biotech, drug R&D grew in 2009 - Mass High Tech Business News - 1 views

  • Biotech, drug R&D grew in 2009
  • The R&D investments by PhRMA members and non-members in the pharmaceutical and biotech sectors reached a record $65.3 billion in 2009, an increase of 1.5 billion
  • there are more than 2,900 medicines in clinical trials or awaiting review
  •  
    The R&D investments by PhRMA members and non-members in the pharmaceutical and biotech sectors reached a record $65.3 billion in 2009, an increase of 1.5 billion despite the recession
1 - 7 of 7
Showing 20 items per page